AstraZeneca flop a fresh blow to cancer immunotherapy combination

LONDON (Reuters) – The concept of combining two immunotherapy drugs to fight lung cancer – not so long ago one of the hottest ideas in cancer research – has suffered a fresh blow from the failure of an AstraZeneca clinical study.

Source: Reuters Medical News

Leave a Reply

Your email address will not be published. Required fields are marked *